WCK-4234

Catalog No. :
ACHYQQ177
CAS No. :
1804915-68-1
Molecular Formula :
C7H8N3NaO5S
Molecular Weight :
269.21

IUPAC Name:sodium (2S,5R)-2-cyano-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate

WCK-4234 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$69.00Login to see priceInquiryInquiry
2mg98%$98.00Login to see priceInquiryInquiry
5mg98%$159.00Login to see priceInquiryInquiry
10mg98%$235.00Login to see priceInquiryInquiry
25mg98%$396.00Login to see priceInquiryInquiry
50mg98%$564.00Login to see priceInquiryInquiry
100mg98%$762.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameWCK-4234
IUPAC Namesodium (2S,5R)-2-cyano-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
Molecular FormulaC7H8N3NaO5S
Molecular Weight269.21
SMILESO=S(ON1[C@]2([H])CC[C@@H](C#N)[N@@](C2)C1=O)([O-])=O.[Na+]
InChI KeyRYJWKSOILDDAHI-RIHPBJNCSA-M
SynonymAvibactam Impurity 46;sodium (2R,5R)-2-cyano-7-oxo-6-azabicyclo[3.2.1]octan-6-yl sulfate;WCK4234;Sulfuric acid, mono[(1R,2S,5R)-2-cyano-7-oxo- 1,6-diazabicyclo[3.2.1]oct-6-yl] ester, sodium salt (1:1);inhibit,carbapenemases,antibacterial,KPC enzymes,diazabicyclooctanes (DBOs),Enterobacteriaceae,Bacterial,Inhibitor;Avibactam Impurity 67 Sodium Salt;WCK-4234 sodium, 10 mM in DMSO
CAS No.1804915-68-1

Synthetic Route by SureRoute

1. ACHYQQ177 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVXKH305 route compound structure diagram
    ACVXKH3051192500-31-4 In Stock
  2. Then
  3. ACHYQQ177 route product structure diagram
    ACHYQQ1771804915-68-1
Inquiry

2. ACHYQQ177 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHYQQ177 route product structure diagram
    ACHYQQ1771804915-68-1
Inquiry

Comments (0)